GKV Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.38M |
| 2 |
Verizon
VZ
|
+$1.36M |
| 3 |
UnitedHealth
UNH
|
+$1.35M |
| 4 |
SPDR Gold Trust
GLD
|
+$608K |
| 5 |
Simon Property Group
SPG
|
+$582K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.98M |
| 2 |
Microsoft
MSFT
|
+$3.46M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$2.73M |
| 4 |
Arista Networks
ANET
|
+$2.5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30% |
| 2 | Healthcare | 14.13% |
| 3 | Consumer Discretionary | 13.2% |
| 4 | Industrials | 10.65% |
| 5 | Financials | 8.44% |
Similar funds
GKV Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, GKV Capital Management held 182 positions worth $201M, down 18% from $245M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
GKV Capital Management withdrew a net $32M in Q1 2025, closing 17 positions and reducing 59 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $2.73M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, GKV Capital Management opened a new position in Alibaba worth $529K.
- GKV Capital Management's largest Q1 2025 buy was Alibaba: 4,000 shares worth $529K.
- GKV Capital Management added most to Citigroup in Q1 2025, an estimated $1.38M increase.
- GKV Capital Management's biggest Q1 2025 reduction was Advanced Micro Devices, cutting an estimated $3.98M.
- GKV Capital Management fully exited Regeneron Pharmaceuticals in Q1 2025, selling an estimated $2.73M.
- GKV Capital Management's ten largest holdings make up 48% of its $201M portfolio in Q1 2025.
- GKV Capital Management opened 22 new positions and closed 17 in Q1 2025.
- GKV Capital Management's portfolio value fell 18% quarter-over-quarter to $201M.
Based on GKV Capital Management's 13F filing for Q1 2025, filed 13 May 2025.